Published in Clin Transplant on January 11, 2010
Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center. J Transplant (2013) 0.75
Renal vein lengthening using gonadal vein reduces surgical difficulty in living-donor kidney transplantation. World J Surg (2012) 0.75
Increasing the supply of kidneys for transplantation by making living donors the preferred source of donor kidneys. Medicine (Baltimore) (2014) 0.75
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Alemtuzumab induction in renal transplantation. N Engl J Med (2011) 4.13
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol (2012) 3.11
Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Kidney Int (2013) 2.12
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res (2002) 1.93
Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol (2006) 1.68
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci U S A (2008) 1.63
Flow Re-direction Endoluminal Device in treatment of cerebral aneurysms: initial experience with short-term follow-up results. J Neurosurg (2014) 1.61
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology (2012) 1.56
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol (2011) 1.56
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology (2010) 1.55
Biological performance of mussel-inspired adhesive in extrahepatic islet transplantation. Biomaterials (2009) 1.55
Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl (2014) 1.50
Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation (2013) 1.50
Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol (2006) 1.50
C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. Transplantation (2015) 1.50
Kidney transplant candidates' understanding of increased risk donor kidneys: a qualitative study. Clin Transplant (2011) 1.48
Early Postoperative Emergency Department Care of Abdominal Transplant Recipients. Transplantation (2015) 1.48
In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation (2006) 1.46
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection. AIDS (2016) 1.45
A model for reactivation of CMV from latency. J Clin Virol (2002) 1.43
When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States. Ann Surg (2016) 1.42
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39
Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. J Allergy Clin Immunol (2008) 1.36
Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant (2009) 1.35
Endovascular treatment of carotid cavernous sinus fistula: A systematic review. World J Radiol (2013) 1.34
Laparoscopic donor nephrectomy 1997 to 2003: lessons learned with 500 cases at a single institution. Surgery (2004) 1.28
Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation (2008) 1.27
Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation (2006) 1.23
Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials (2009) 1.21
Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation (2008) 1.20
Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol (2013) 1.20
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol (2009) 1.17
The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. Transplantation (2014) 1.15
Proposed classification of complications after live donor nephrectomy. Urology (2006) 1.15
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes. Surgery (2009) 1.13
The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg (2010) 1.11
Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis (2005) 1.11
In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol Imaging (2006) 1.11
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg (2011) 1.11
Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med (2012) 1.10
Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials (2010) 1.09
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08
Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. Transplantation (2007) 1.08
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation (2009) 1.06
Laparoscopic liver surgery for everyone: the hybrid method. Surgery (2007) 1.05
Pretransplant evaluation of renal transplant candidates. Semin Nephrol (2002) 1.03
A review of quality of life instruments used in liver transplantation. J Hepatol (2009) 1.03
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol (2013) 1.02
Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol (2008) 1.02
Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimmun (2012) 1.01
Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia. Tissue Eng Part A (2013) 1.01
Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials (2011) 1.00
Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. J Immunol (2010) 1.00
Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis. J Immunol (2008) 0.98
Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation (2015) 0.96
A critical evaluation of the morbidity and mortality conference. Am J Surg (2002) 0.95
Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl (2005) 0.95
Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int (2012) 0.94
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation (2011) 0.93
TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol (2010) 0.92
Informed consent and decision-making about adult-to-adult living donor liver transplantation: a systematic review of empirical research. Transplantation (2011) 0.92
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Transplantation (2011) 0.91
Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. Transl Res (2008) 0.91
Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models. Biomaterials (2011) 0.91
Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver Transpl (2015) 0.90
Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function. J Endocrinol (2010) 0.90
Early and midterm results of complex cerebral aneurysms treated with Silk stent. Neuroradiology (2012) 0.90
Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance. J Immunol (2012) 0.90
Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2014) 0.89
Comparative study of regenerative potential of beta cells from young and aged donor mice using a novel islet transplantation model. Transplantation (2009) 0.89
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest (2014) 0.89
The epididymal fat pad as a transplant site for minimal islet mass. Transplantation (2007) 0.89